In conclusion, we evaluated an immunohistochemical assay to detect the negative expression of five subunits of SWI/SNF in NSCLC on the TMA platform, focusing on the clinicopathological relevance and prognostic significance of SMARCA2-negative expression in NSCLC. This evidence concerns the gene SMARCA2 and non-small cell lung carcinoma.